147 related articles for article (PubMed ID: 24438498)
1. A prostaglandin D-synthase-positive mast cell gradient characterizes scalp patterning.
Larson AR; Zhan Q; Johnson E; Fragoso AC; Wan M; Murphy GF
J Cutan Pathol; 2014 Apr; 41(4):364-9. PubMed ID: 24438498
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the culture and growth of dermal papilla cells from hair follicles from non-balding and balding (androgenetic alopecia) scalp.
Randall VA; Hibberts NA; Hamada K
Br J Dermatol; 1996 Mar; 134(3):437-44. PubMed ID: 8731666
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia.
Garza LA; Liu Y; Yang Z; Alagesan B; Lawson JA; Norberg SM; Loy DE; Zhao T; Blatt HB; Stanton DC; Carrasco L; Ahluwalia G; Fischer SM; FitzGerald GA; Cotsarelis G
Sci Transl Med; 2012 Mar; 4(126):126ra34. PubMed ID: 22440736
[TBL] [Abstract][Full Text] [Related]
4. Does prostaglandin D2 hold the cure to male pattern baldness?
Nieves A; Garza LA
Exp Dermatol; 2014 Apr; 23(4):224-7. PubMed ID: 24521203
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
Hamada K; Randall VA
Br J Dermatol; 2006 Apr; 154(4):609-18. PubMed ID: 16536801
[TBL] [Abstract][Full Text] [Related]
6. Dermal fibrosis in male pattern hair loss: a suggestive implication of mast cells.
Won CH; Kwon OS; Kim YK; Kang YJ; Kim BJ; Choi CW; Eun HC; Cho KH
Arch Dermatol Res; 2008 Mar; 300(3):147-52. PubMed ID: 18286292
[TBL] [Abstract][Full Text] [Related]
7. Morphological and morphometric study of the androgenetic alopecic scalp using two- and three-dimensional analysis comparing regional differences.
Kim JN; Lee JY; Shin KJ; Gil YC; Koh KS; Song WC
Br J Dermatol; 2014 Jun; 170(6):1313-8. PubMed ID: 24446778
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of skin sclerosis by 15deoxy delta12,14-prostaglandin J2 and retrovirally transfected prostaglandin D synthase in a mouse model of bleomycin-induced scleroderma.
Kohno S; Endo H; Hashimoto A; Hayashi I; Murakami Y; Kitasato H; Kojima F; Kawai S; Kondo H
Biomed Pharmacother; 2006 Jan; 60(1):18-25. PubMed ID: 16337105
[TBL] [Abstract][Full Text] [Related]
9. Scarring alopecia associated with mastocytosis.
Xu X; Solky B; Elenitsas R; Cotsarelis G
J Cutan Pathol; 2003 Oct; 30(9):561-5. PubMed ID: 14507404
[TBL] [Abstract][Full Text] [Related]
10. Increased scalp skin and serum 5 alpha-reductase reduced androgens in a man relevant to the acquired progressive kinky hair disorder and developing androgenetic alopecia.
Boudou P; Reygagne P
Arch Dermatol; 1997 Sep; 133(9):1129-33. PubMed ID: 9301590
[TBL] [Abstract][Full Text] [Related]
11. Increase of mast cells in the alopecia lesion of mice.
Tanii T; Okada T; Fukai K; Nakagawa K; Hamada T
Acta Derm Venereol; 1985; 65(1):64-6. PubMed ID: 2578708
[TBL] [Abstract][Full Text] [Related]
12. Hair counts in scalp biopsy of males and females with androgenetic alopecia compared with normal subjects.
Aslani FS; Dastgheib L; Banihashemi BM
J Cutan Pathol; 2009 Jul; 36(7):734-9. PubMed ID: 19519605
[TBL] [Abstract][Full Text] [Related]
13. Quantitative study of the human hair follicle in normal scalp and androgenetic alopecia.
Alcaraz MV; Villena A; Pérez de Vargas I
J Cutan Pathol; 1993 Aug; 20(4):344-9. PubMed ID: 8227610
[TBL] [Abstract][Full Text] [Related]
14. Contrast enhanced phototrichogram (CE-PTG): an improved non-invasive technique for measurement of scalp hair dynamics in androgenetic alopecia--validation study with histology after transverse sectioning of scalp biopsies.
Van Neste DJ
Eur J Dermatol; 2001; 11(4):326-31. PubMed ID: 11399539
[TBL] [Abstract][Full Text] [Related]
15. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
[TBL] [Abstract][Full Text] [Related]
16. Histological features of peripilar signs associated with androgenetic alopecia.
Deloche C; de Lacharrière O; Misciali C; Piraccini BM; Vincenzi C; Bastien P; Tardy I; Bernard BA; Tosti A
Arch Dermatol Res; 2004 Mar; 295(10):422-8. PubMed ID: 14758487
[TBL] [Abstract][Full Text] [Related]
17. Cicatricial marginal alopecia: is it all traction?
Goldberg LJ
Br J Dermatol; 2009 Jan; 160(1):62-8. PubMed ID: 18811691
[TBL] [Abstract][Full Text] [Related]
18. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-1: roles in androgenetic alopecia.
Panchaprateep R; Asawanonda P
Exp Dermatol; 2014 Mar; 23(3):216-8. PubMed ID: 24499417
[TBL] [Abstract][Full Text] [Related]
20. Stem cell factor/c-Kit signalling in normal and androgenetic alopecia hair follicles.
Randall VA; Jenner TJ; Hibberts NA; De Oliveira IO; Vafaee T
J Endocrinol; 2008 Apr; 197(1):11-23. PubMed ID: 18372228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
